retatrutide case study just delivered the first top-line Phase 3 results for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 Full article: Efficacy and safety

Kusunoki M, Sato D, Nakamura T, Oshida Y, Tsutsui H, Natsume Y, Tsutsumi K, Miyata T

The baseline HbA1c in the tirzepatide arms was 8.23%8.36% and 8.37% in the placebo group

Semaglutide GLP-1 Injections for Medical Weight Loss in Phoenix AZ Semaglutide GLP-1 injections are an effective tool for medical weight loss, aiding significant and sustainable weight reduction

Research has consistently shown that stigma and embarrassment are significant barriers to seeking obesity treatment

Clinical Trial Pipeline: 170+ Peptides in Active Development More than 170 peptides are in active clinical development, with over 280 peptide drugs undergoing preclinical and clinical studies

MEDVi's providers may discuss lifestyle changes, but it isn't the centerpiece of the program